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Abstract  31 
Introduction 32 
Pregnancy complicated by diabetes mellitus (DM) is a central obstetric problem often complicated by fetal 33 
macrosomia and increased risk of intrapartum asphyxia. This risk might be explained by fetoplacental 34 
vascular abnormalities. This study aimed to investigate the fetoplacental vascular volume by placental CT 35 
angiography in normal pregnancies and in pregnancies complicated by type 1 DM (T1DM), diet controlled 36 
gestational DM (GDMd), and insulin treated gestational DM (GDMi). 37 
Methods 38 
Postpartum, barium contrast enhanced placental CT angiography was performed in 27 normal pregnancies 39 
and 25 DM pregnancies (8 T1DM, 8 GDMd, and 9 GDMi). The fetoplacental vascular volume/placenta 40 
weight (FVV/PW)-ratio and fetoplacental vascular volume/birth weight (FVV/BW)-ratio of each diabetic 41 
group were compared to the normal group with multiple regression analysis adjusted for GA. In all 42 
pregnancies a standardized histopathological placental examination was performed postpartum. 43 
Results 44 
In normal pregnancies, the fetoplacental vascular volume increased with GA (p<0.001), placental weight 45 
(p<0.001), and birth weight (p<0.001). In T1DM and GDMi pregnancies, the gestational age adjusted 46 
placental weight and the birth weight were increased when compared to normal pregnancies (p<0.05). The 47 
FVV/BW-ratio was significantly reduced in both T1DM and GDMi pregnancies when compared to normal 48 
pregnancies (p=0.003 and p=0.009, respectively).  49 
Discussion 50 
This study demonstrates, that in insulin treated DM pregnancies the fetus as well as the placenta is larger 51 
than normal. However, despite a large placenta, a relatively smaller fetoplacental vascular volume supplies 52 
the macrosomic fetus. This finding might explain why fetuses from insulin treated DM pregnancies have 53 
high vulnerability to intrauterine and intrapartum asphyxia.  54 
Keywords 55 
Diabetes mellitus, placenta, CT angiography, vasculature, fetoplacental vascular volume, gestational 56 
diabetes 57 
Abbreviations 58 
Computed tomography angiography (CTA), diabetes mellitus (DM), diet controlled gestational diabetes 59 
mellitus (GDMd), fetoplacental vascular volume/birth weight-ratio (FVV/BW-ratio), fetoplacental vascular 60 
volume/placenta weight-ratio (FVV/PW-ratio), gestational age (GA), insulin treated gestational diabetes 61 
mellitus (GDMi), magnetic resonance angiography (MRA), and type 1 diabetes mellitus (T1DM). 62 
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Introduction 63 
Pregnancies complicated by diabetes mellitus (DM), both type 1 DM (T1DM) and gestational DM (GDM), 64 
are a central obstetric challenge, as the fetal and maternal morbidity and perinatal mortality is high[1]. It is 65 
well described that DM pregnancies are associated with neonatal complications such as fetal macrosomia, 66 
perinatal asphyxia, and metabolic syndrome in later life[1]. The increased risk of intrauterine and 67 
intrapartum asphyxia in pregnancies complicated by DM may partly relay on the increased metabolic 68 
demand of the macrosomic diabetic fetus and a decreased transplacental oxygen transfer capacity due to 69 
altered oxygen binding capacity of hemoglobin[2]. However fetoplacental vascular abnormalities related to 70 
DM may also contribute to the increased risk[3–5].  71 
It is known that DM pregnancies are associated with increased placental weight and birth weight and 72 
an increased birth weight/placental weight-ratio[6]. Current knowledge on the fetoplacental vasculature in 73 
DM pregnancies is based on macroscopic examinations[7], histomorphometry[3,8–16], stereology[4,17–74 
20], x-ray angiograms[21], and measurements of the placental residual blood volume after birth[22]. In 75 
T1DM pregnancies conflicting results are demonstrated as some studies describe an increased 76 
fetoplacental vascular volume, surface area, and capillary length compared to normal[3,4,8,9,17–19,22], 77 
while others describe decreased vessel diameter and number of vessels[7,10–15,21]. Also in GDM 78 
pregnancies, existing knowledge on the fetoplacental vasculature demonstrates conflicting results with 79 
studies reporting increased vascular volume[15], surface area[15], and number of vessels[12,23] as well as 80 
decreased number of vessels[20,24]. The inconsistent findings in the literature may be explained by 81 
differences in glycemic control, treatment regime, and lack of methods to demonstrate vascular 82 
pathology[25].  83 
Imaging technologies such as placental computed tomography angiography (CTA) and magnetic 84 
resonance angiography (MRA) have a great potential to investigate the fetoplacental vasculature in three-85 
dimensions (3D). By using these methods the fetoplacental vasculature has been investigated in normal 86 
pregnancies[26–29], however to the best of our knowledge CTA has never been performed in pregnancies 87 
complicated by different types of DM. 88 
To improve our understanding of the perinatal risk of asphyxia associated with DM, a better 89 
knowledge of the fetoplacental vasculature is essential. Therefore this study aimed to investigate the 90 
fetoplacental vascular volume by using postpartum 3D placental CTA in normal pregnancies in comparison 91 
to pregnancies complicated by DM (T1DM, diet controlled GDM (GDMd), and insulin treated GDM (GDMi)). 92 
Methods 93 
Twenty-five placentas (35-41 weeks’ gestation) from singleton pregnancies complicated by DM (8 T1DM 94 
placentas, 8 GDMd placentas, and 9 GDMi placentas) were included in the study[30,31]. 32 placentas (30-95 
42 weeks’ gestation) from normal singleton pregnancies constituted the control group. We excluded 96 
stillbirths, abnormal fetal karyotype or congenital malformations, and pregnancies with clinical signs of 97 
placental insufficiency (umbilical artery Doppler flow Pulsatility index (PI) Z-score ≥ 2[32], cerebroplacental 98 
Doppler ratio Z-score ≤ -2[33] and birth weight ≤ - 22%[34]. All placentas were collected at Aalborg 99 
University Hospital, Denmark, between July 1st, 2015 and December 1st, 2016. The Danish National Ethics 100 
Committee (N-20150018) and the Danish Data Protection Agency (2008-58-0028) approved the study, and 101 
all participants gave oral and written informed consent. Maternal and pregnancy characteristics are 102 
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presented in Table 1. Data were collected from medical records and the electronic ultrasound database 103 
Astraia version 1.24.7 (Astraia Software Gmbh, Munich, Germany).  104 
Just after delivery, the placentas were stored at -5°C, and on the day of CTA the placenta was thawed 105 
in a warm water bath (37°C). The umbilical cord vessels were cannulated 5cm from the umbilical cord 106 
insertion using 3 venous cannulas size 1.3x32mm (BD Venflon Pro, Helsingborg, Sweden). The placenta was 107 
flushed with a saline 9mg NaCl/ml and Heparin 4.5IE/ml (Leo Pharma A/S, Ballerup, Denmark) solution until 108 
the venous efflux was clear. Hereafter a heated (<40°C) contrast mixture of gelatin 0.05g/ml (Urtegaarden 109 
Djursland, Allingåbro, Denmark), barium sulphate 0.17g/ml (E-Z Em Inc, Westbury, NY, USA), and saline 110 
9mg NaCl/ml was injected with a hand syringe. When the contrast mixture appeared in the venous efflux, 111 
the vein was plugged, and injection was continued until resistance was felt. Hereafter the placenta was 112 
cooled on ice to set the gelatin solution (Figure 1 (A and C)).   113 
CTA was performed on a 128-slice Siemens SOMATOM Definition Flash scanner (Siemens Healthcare 114 
GmbH, Erlangen, Germany) with software version VA48A and the flowing parameters: 0.6mm slice 115 
thickness, 0.4mm increment, 1° pitch, 140kV, effective 200mAs, and 1sec rotation time. Post processing 116 
analysis was performed using the commercial software AW Server version 3.0 (GE Healthcare, Little 117 
Chalfont, Great Britain) to calculate the fetoplacental vascular volume by computing the volume of all 118 
voxels above 550HU (Figure 1 (B, D, and E)). All 3D reconstructions of the fetoplacental vasculature were 119 
visually inspected. Five placentas were excluded from the normal group due to insufficient contrast filling 120 
of the fetoplacental vessels. No placentas were excluded from the DM group. 121 
After the CTA, a standardized postnatal histopathological examination according to the Amsterdam 122 
consensus guideline[35] was performed by experienced placental pathologists (PB and AP), who were 123 
blinded to the CTA vascular outcome, but not the clinical information. Selected diabetic histopathological 124 
findings are reported in Table 3 using the following references for placental weight[36], delayed villous 125 
maturation[35], and the umbilical cord[37]. 126 
In normal pregnancies, the association between the fetoplacental vascular volume and the following 127 
variables; gestational age at birth (GA), placental weight, and birth weight, was investigated by linear 128 
regression analysis. In each of the diabetic groups, the fetoplacental vascular volume, the fetoplacental 129 
vascular volume/placental weight (FVV/PW)-ratio and the fetoplacental vascular volume/birth weight 130 
(FVV/BW)-ratio was compared to the normal group by multiple linear regression adjusting for GA. p<0.05 131 
was considered significant. All analyses were performed in SPSS Statistics version 25.0 (IBM, North Castle, 132 
New York, USA). 133 
Results  134 
As demonstrated in Table 1, the placental weight and birth weight (given as Z-scores and hence corrected 135 
for GA) were increased in pregnancies complicated by T1DM (p=0.026 and p<0.001, respectively) and in 136 
GDMi (p=0.002 and p=0.003, respectively) pregnancies. In addition, the T1DM and GDMi groups had a 137 
higher HbA1c when compared to GDMd pregnancies, indicating poorer glycemic control in these diabetic 138 
groups. Given the small number of patients in this study, the rare event of umbilical cord pH < 7 and Apgar 139 
score < 7 five minutes postpartum was not apparent. However, there was a trend towards more caesarian 140 
sections (elective and acute) among the patients with insulin dependent diabetes.  141 
As illustrated in Figure 1, the 3D reconstruction of the segmented fetoplacental vascular volume 142 
included both the chorionic vessels on the placental surface and the stem villi vessels that bend 143 
perpendicularly to the placental surface, which further branches into intermediate villi vessels (Figure 1E). 144 
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The smallest vessels of the fetoplacental vascular tree (capillaries) were not included as a part of the 145 
computed fetoplacental vascular volume. 146 
In normal pregnancies at term (GA 40+0) the fetoplacental vascular volume was 172.2ml (95% CI: 147 
154.2-189.9 ml/kg), and we demonstrated a positive linear association between the fetoplacental vascular 148 
volume and GA (r2=0.585, p<0.001), placental weight (r2=0.405, p<0.001), and birth weight (r2=0.499, 149 
p<0.001) (Figure 2). In the DM groups, the fetoplacental vascular volume did not differ from that in normal 150 
pregnancies at equivalent GA. 151 
In normal pregnancies at term (GA 40+0) the FVV/BW-ratio was 48.9 ml/kg (95% CI: 44.5-56.7ml/kg). 152 
In all DM groups the FVV/BW-ratio was lower, however this difference was only significant in the insulin 153 
dependent DM groups; T1DM (-16.2ml/kg, p=0.003), GDMi (-12.1ml/kg, p=0.009), and GDMd (-7.8ml/kg, 154 
p=0.198). 155 
In normal pregnancies at term (GA 40+0) the FVV/PW-ratio was 33.9ml/kg (95% CI: 32.9-37.9ml/kg), 156 
and this ratio was reduced in all DM groups, but the difference was only significant for pregnancies 157 
complicated by GDMi (-81.5ml/kg, p=0.012) and with a strong trend in T1DM (-66.0ml/kg, p=0.068) (Table 158 
2). 159 
The placental histopathological examination is presented in Table 3. Characteristic diabetic 160 
abnormalities are seen predominantly in the insulin treated diabetic pregnancies, as two or more diabetic 161 
findings are seen in 12.5% of pregnancies complicated by T1DM and in 44.4% of pregnancies complicated 162 
by GDMi. 163 
Discussion  164 
This study demonstrated that in normal pregnancies the fetoplacental vascular volume increased with GA, 165 
placental weight, and birth weight. In pregnancies complicated by T1DM and GDMi, the placental weight 166 
and birth weight was higher than normal. However, in these pregnancies the relative fetoplacental vascular 167 
volume was reduced, as demonstrated by a lower FVV/PW-ratio and FVV/BW-ratio. These findings indicate, 168 
that the large placenta in pregnancies complicated by insulin dependent diabetes has relatively fewer 169 
fetoplacental vessels, and therefore a relatively smaller fetoplacental volume supplies the macrosomic 170 
diabetic fetus. This finding might explain one of the underlying mechanisms why fetuses from insulin 171 
dependent diabetic pregnancies are more vulnerable to asphyxia during pregnancy and labor. 172 
This study had some methodological limitations. Proper placental preparation is crucial to obtain 173 
reliable fetoplacental vascular assessments. To ensure sufficient contrast filling of the entire fetoplacental 174 
vasculature without presence of intravascular blood clots, the placentas in this study were frozen 175 
postpartum, which is known to reduce clotting without adverse effects on the fetoplacental 176 
vasculature[38–40]. Furthermore, the thawed placentas were flushed with heparinized saline to remove 177 
vascular clots prior to contrast injection. The fetoplacental vascular volume may have varied according to 178 
the degree of vascular contrast filling injected by a hand syringe. However in this study, one person (MØT) 179 
performed the contrast injection, and in each placenta contrast injection was performed uniformly until a 180 
specific resistance was felt. To avoid contrast drainage we added gelatin to the contrast solution, and the 181 
contrast-perfused placenta was cooled on ice packs to set the contrast solution.  182 
Strength of our study was the ability to demonstrate the entire fetoplacental vasculature except for 183 
the smallest vessels (capillaries). The majority of previous studies is based on placental biopsies[3,9,14,15], 184 
which might not reflect the placental pathology of the entire placenta. It is well known that the normal 185 
placenta has a heterogeneous vessel maturation[41], and also the diabetic placenta is known to have focal 186 
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pathology such as dysmature villous structures[25]. Another strength of the present method was the 187 
demonstration of the fetoplacental vasculature in 3D. 3D reconstruction provides information of spatial 188 
vessel architecture such as the fetoplacental vascular volume, which is not available by 2D imaging[42] 189 
which is the basis of the majority of previous studies[3,7,9,14,15,20,21]. Lastly, angiography allows for 190 
histopathological placental examination to be performed following the vascular investigation, which is not 191 
available with comparable methods such as corrosion casting.  192 
A limitation of the study design was the relatively small study population. GDM pregnancies were 193 
grouped according to the White Classification of Diabetes in Pregnancy[43], but because of the small 194 
number of T1DM pregnancies in this study, this group was not further subdivided.  195 
Strength of the study was the placental histopathological examination that confirmed, that placental 196 
pathology is predominantly seen in pregnancies complicated by insulin dependent diabetes. Another 197 
strength was the adjustment for GA in the analysis when comparing the fetoplacental vasculature between 198 
groups. This is of major importance, as the fetoplacental vascular volume is known to increase dramatically 199 
as pregnancy advances[44,45], which is also in accordance with the findings of our study. 200 
In normal pregnancies, this study demonstrated that the normal fetoplacental vascular volume at 201 
term is 172.2ml (95% CI: 154.2-189.9 ml/kg). As demonstrated by images of the 3D segmentation, the 202 
vascular volume includes the chorionic vessels, the stem villi vessels, and the intermediate villi vessels. This 203 
finding is very much in line with the previous published literature, where the normal fetoplacental vascular 204 
volume is estimated to be 5-159ml based on residual placental blood-volume[22,46] or 12-124ml based on 205 
MR-angiography[27],. The normal fetoplacental vascular volume in this study is reassuring, as it indicates 206 
that under-segmentation was not a major limitation of this study. Furthermore, a positive linear association 207 
was found between the fetoplacental vascular volume and GA. This finding is in accordance with a previous 208 
study based on stereological analysis of placental biopsies demonstrating a linear increase of stem and 209 
intermediate villi vessel volume throughout pregnancy[47]. Furthermore, our study demonstrated a linear 210 
correlation between the fetoplacental vascular volume and placental weight and birth weight. This finding 211 
is in accordance with a previous study on placental MRA in normal pregnancies at term by Rasmussen et 212 
al[27]. In contrast to our study, Rasmussen et al. were not able to demonstrate an association between 213 
placental vascular volume and placental weight. However, this discrepancy may be explained by a different 214 
range of GA included in the two studies, as our study included placentas at a wide range of GA (30-42 215 
weeks’ gestation) as compared to Rasmussen et al. who included term placentas. 216 
We found an increased placental weight and birth weight in pregnancies complicated by insulin 217 
dependent DM, which is in line with previous literature[6]. However there is evidence to support that this 218 
pathology should also be found among diet dependent diabetes[48]. In this study, the GDMd group had a 219 
lower HbA1c suggesting a good glycemic control, which may explain why this group did not demonstrate 220 
such pathology in our study. 221 
Furthermore, we found that in all three DM groups the fetoplacental vascular volume did not differ 222 
from that in normal pregnancies. In previous studies, the fetoplacental vascular volume has been 223 
investigated by different methods, which could explain the rather conflicting results. By estimating the 224 
placental residual blood volume, Klebe et al[22] found an increased fetoplacental vascular volume in DM 225 
pregnancies when compared to normal pregnancies. However, another study by Singer et al[14] found no 226 
difference in the vascular volume and surface areas of the chorionic vessels and stem villi vessels when 227 
estimated by placental histological examination. 228 
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In this study, intrauterine and intrapartum asphyxia, defined as umbilical blood pH < 7 and Apgar 229 
score < 7 after 5 minutes, was not present. This might be due to a very small number of patients included in 230 
the study, appropriate antenatal monitoring, and adequate obstetric intervention of the included diabetic 231 
pregnancies. In Table 1, it should be noted, that there is a trend towards a higher proportion of elective and 232 
acute cesarean section among the DM pregnancies.  233 
The disparities in FVV/BW-ratio among insulin dependent and insulin independent DM pregnancies 234 
in this study might be caused by differences in the placental pathophysiology. As fetoplacental vascular 235 
abnormalities are hypothesized to result from hypoxia caused by fetal and maternal hyperglycemia[1], the 236 
observed differences might indicate differences in time of onset and severity of hyperglycemia between 237 
the different DM types and differences in preexisting maternal factors[49]. It is known that when DM is 238 
well controlled during pregnancy, the fetoplacental vasculature is normally developed and the neonatal 239 
outcome improved[25]. The measured HbA1C values in this study is highest in T1DM both pre-gestational 240 
and during pregnancy (Table 1), but time for onset of hyperglycemia in the GDM pregnancies cannot be 241 
withdrawn. Future research is recommended to consider this. 242 
In conclusion, we have demonstrated that the placental weight and birth weight is increased in 243 
insulin dependent diabetic pregnancies, however the fetoplacental vasculature is not correspondingly 244 
increased. This study highlights that insulin dependent pregnancies are subject to relative placental 245 
insufficiency, as in these pregnancies the macrosomic fetus is supplied by a relatively smaller fetoplacental 246 
vascular volume. This finding might explain one of the underlying mechanisms, why fetuses from insulin 247 
dependent diabetic pregnancies are more vulnerable to asphyxia during pregnancy and labor. 248 
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Figure legends 396 
 397 
Figure 1: Images of a placenta from a normal pregnancy GA 37+4 (A and B) and a placenta from a pregnancy complicated by type 1 398 
diabetes mellitus, GA 37+1 (C and D). Macroscopic photography (A and C) and a 3D reconstruction of the fetoplacental blood 399 
vessels (B and D).  400 
 401 
Figure 2: Association between fetoplacental vascular volume (ml) and A) gestational age at birth (weeks), B) placental weight (g), 402 
and C) birth weight (g). The solid lines indicate ordinary least squares fit. The dashed lines indicate 95% confidence interval for the 403 
normal placentas. Normal placentas (open circle), type 1 diabetes mellitus (T1DM) (squares), diet controlled gestational diabetes 404 
mellitus (GDMd) (triangles), insulin treated gestational diabetes mellitus (GDMi) (pentagons). 405 
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Table 1: Maternal, placental, and neonatal characteristics of included patients. 406 
Characteristics Normal (N=27) T1DM (N=8) GDMd (N=8) GDMi (N=9) 
   p-value  p-value  p-value 
Maternal age at birth, yr 29.0 (27.0 – 34.0) 27.5 (26.5 – 31.0) 0.433 29.0 (27.0 - 34.8) 0.884 31.0 (27.0 – 36.5) 0.443 
Pre-gestational maternal 
BMI, kg/m
2
 
24.1 (20.7 – 30.1) 29.1 (26.8 – 33.5) 0.027 26.6 (20.4-31.9) 0.550 28.2 (25.9 – 34.6) 0.086 
Nulliparity 48.1 (13/29) 37.5 (3/8) 0.700 50.0 (4/8) 1.000 33.3 (3/9) 0.700 
Maternal smoking 14.8 (4/29) 0.0 (0/8) 0.553 37.5 (3/8) 0.312 22.2 (2/9) 0.627 
Umbilical artery Doppler, Z-
score[32] 
0.3 (-0.6 – 0.9) (N=22) 0.2 (-0.3 – 1.6) 0.185 -0.1 (-0.6 – 0.4) 0.530 0.4 (-0.3 – 0.9) 0.362 
Cerebroplacental-ratio, Z-
score[33] 
-0.5 (-0.7 – 0.2) (N=7) -1.3 (-3.7 - -0.7) (N=4) 0.065 -1.1 (-1.3 - .) (N=2) 0.283 0.0 (-1.5 - .) (N=3) 0.922 
Gestational age, weeks 38.9 (34.3 – 40.6) 36.9 (35.9 – 37.1) 0.192 40.6 (39.4 – 41.1) 0.104 37.6 (36.7 - 38.2) 0.295 
Birth weight, Z-score[34] -0.4 (-0.7 – 0.5) 2.2 (1.5– 3.2) <0.001 0.0 (-0.1 – 2.2) 0.286 1.1 (0.2 – 3.2) 0.003 
Placental weight, Z-score -0.1 (-0.4 – 0.4) 0.5 (0.0 – 1.9) 0.026 -0.2 (-0.9 – 0.8) 0.784 1.5 (0.4 – 2.3) 0.002 
Umbilical venous vessel pH 
< 7.00 
0.0 (0/27) 0.0 (0/8) - 0.0 (0/8) - 0.0 (0/9) - 
Apgar score < 7 after 5 min 0.0 (0/27) 0.0 (0/8) - 0.0 (0/8) - 0.0 (0/9) - 
Delivery mode 
• Vaginal birth 
• Elective cesarean 
section 
• Acute cesarean 
section 
 
• 70.4 (19/27) 
• 7.4 (2/27) 
 
• 22.2 (6/27) 
 
• 37.5 (3/8) 
• 25.0 (2/8) 
 
• 37.5 (3/8) 
 
0.116 
0.218 
 
0.396 
 
• 75.0 (6/8) 
• 12.5 (1/8) 
 
• 12.5 (1/8) 
 
1.000 
0.553 
 
1.000 
 
• 33.3 (3/9) 
• 33.3 (3/9) 
 
• 33.3 (3/9) 
 
0.111 
0.088 
 
0.660 
Shoulder dystocia 0.0 (0/27) 0.0 (0/8) - 0.0 (0/8) - 0.0 (0/9) - 
Vacuum delivery 11.1 (3/27) 0.0 (0/8) 1.000 0.0 (0/8) 1.000 0.0 (0/9) 0.558 
Postpartum bleeding 
>500ml 
14.8 (4/27) 0.0 (0/8) 0.559 12.5% (1/8) 1.000 0.0 (1/9) 0.553 
Maternal age at DM debut, 
yr 
- 12.5 (3.0 – 17.8) - 29.0 (27.0 - 34.8) - 31.0 (27.0 – 36.5) - 
Gestational age at debut, 
weeks 
- - - 30.9 (28.8 – 33.2) - 28.6 (21.0 – 30.6) - 
HbA1c, mmol/mol -  -  -  - 
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Data are given as median (IQR) or % (n/N). All p-values indicate comparison to normal pregnancy. The continuous data are analyzed with independent samples Student t-test or Mann-407 
Whitney U-test based on the appearance of normal distribution, and categorical data are analyzed with Fishers exact test.  GDMd = diet controlled gestational diabetes mellitus, GDMi 408 
= insulin treated gestational diabetes mellitus, T1DM = type 1 diabetes mellitus. 409 
 410 
 411 
• Pre-gestational 
(T1DM) or pre-
treatment (GDM) 
• 1st trimester 
• 2nd trimester 
 
• 3rd trimester 
• 58.0 (51.25 – 90.0) 
 
 
• 55.0 (46.8 – 67.0) 
• 50.0 (42.5 – 60.3) 
 
• 52.0 (49.5 – 57.8) 
• 31.5 (28.8-35.8) 
 
 
• - 
• 37.0 (N=1) 
 
• 32.0 (29.5 – 38.5) 
• 39.0 (36.0 – 45.5) 
 
 
• - 
• 37.0 (33.8 – 38.0) 
(N=4) 
• 41.0 (34.0 – 46.5) 
White classification[43], 
class 
- C: 50.0 (4/8) 
D: 25.0 (2/8) 
R: 25.0 (2/8) 
- A1: 8/8 - A2: 9/9 - 
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 412 
 413 
 414 
Table 2: Summary of multiple regression analysis. The normal pregnancies are the reference. 415 
 Unstandardized coefficients p-value 95% confidence interval for B 
B Std. Error Lower bound Upper bound 
Fetoplacental vascular volume (ml) 
T1DM  -14.3 15.2 0.356 -45.3 16.8 
GDMd  -18.6 19.9 0.357 -59.3 22.0 
GDMi  -10.9 13.9 0.440 -39.2 17.4 
Fetoplacental vascular volume / placental weight ratio (ml/kg) 
T1DM  -66.0 34.9 0.068 -137.2 5.2 
GDMd  -48.8 40.0 0.231 -130.2 32.6 
GDMi  -81.5 30.6 0.012 -143.7 -19.3 
Fetoplacental vascular volume / birth weight ratio (ml/kg) 
T1DM  -16.2 49.5 0.003 -26.3 -6.1 
GDMd  -7.8 5.9 0.198 -19.8 4.3 
GDMi  -12.1 4.4 0.009 -21.0 -3.3 
GDMd = diet controlled gestational diabetes mellitus, GDMi = insulin treated gestational diabetes mellitus, T1DM = type 1 diabetes mellitus. 416 
 417 
Table 3: Diabetic placental histopathological findings. 418 
Placenta pathology \ Group Normal T1DM GDMd GDMi 
Large placental weight, p>90 [36] 14.8 (4/27) 37.5 (3/8) 12.5 (1/8) 55.6 (5/9) 
Delayed villous maturation [35] 0.0 (0/27) 25.0 (2/8) 0.0 (0/8) 33.3 (3/9) 
Long umbilical cord [37] 22.2 (6/27) 12.5 (1/8) 12.5 (1/8) 33.3 (3/9) 
≥ 2 diabetic findings 7.4 (2/27) 12.5 (1/8) 0.0 (0/8) 44.4 (4/9) 
Data are given as % (n/N). GDMd = diet controlled gestational diabetes mellitus, GDMi = insulin treated gestational diabetes mellitus, T1DM = type 1 diabetes mellitus. 419 
 420 
 421 
 422 
 423 
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Highlights 
 
• Pregnancies complicated by diabetes (DM) are at high risk of intrapartum asphyxia. 
• This risk may be related to fetoplacental vascular abnormalities. 
• This study examines the fetoplacental vascular volume by placental CT angiography. 
• In insulin dependent DM the fetoplacental vascular volume/birthweight-ratio is low. 
• This finding might partly explain the higher vulnerability to fetal asphyxia. 
 
